Search research articles
Contact Us
Filters
Showing results (281-290 of 287) with videos related to
Page
of 29
Sort By:
You have reached the last page of results.
This site can display upto 287 results.
The Ocular Surface
|
November 26, 2018
Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trials
John D Sheppard, Gail L Torkildsen, Joel A Geffin, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association
|
August 1, 2021
Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial
Roberto Gonzalez-Salinas, Paul Karpecki, Elizabeth Yeu, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry
|
March 28, 2024
The impact of Demodex blepharitis on patient symptoms and daily life
Melissa Barnett, Blake Simmons, Patrick Vollmer, et al.
Investigative Ophthalmology & Visual Science
|
January 11, 2019
Randomized, Controlled, Double-Masked, Multicenter, Pilot Study Evaluating Safety and Efficacy of Intranasal Neurostimulation for Dry Eye Disease
Geoffrey S Cohn, Dean Corbett, Abi Tenen, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
January 1, 1978
[Intraoperative and postoperative immediate autotransfusion in open heart surgery under profound hypothermia without pump-oxygenator--development of an immediate autotransfusion system and its clinical applications (author's transl)]
K Matsumoto, Y Koga, N Baba, et al.
Cornea
|
February 9, 2024
Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study
Ehsan Sadri, James D Paauw, Joseph B Ciolino, et al.
ESMO Open
|
November 28, 2021
Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)
Y Nakamura, K Namikawa, S Yoshikawa, et al.
Page
of 29
Search research articles
Search
Showing results (281-290 of 287) with videos related to
Sort By:
Page
of 29
You have reached the last page of results.
This site can display upto 287 results.
The Ocular Surface
|
November 26, 2018
Characterization of tear production in subjects with dry eye disease during intranasal tear neurostimulation: Results from two pivotal clinical trials
John D Sheppard, Gail L Torkildsen, Joel A Geffin, et al.
Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association
|
August 1, 2021
Safety and efficacy of lotilaner ophthalmic solution, 0.25% for the treatment of blepharitis due to demodex infestation: A randomized, controlled, double-masked clinical trial
Roberto Gonzalez-Salinas, Paul Karpecki, Elizabeth Yeu, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry
|
March 28, 2024
The impact of Demodex blepharitis on patient symptoms and daily life
Melissa Barnett, Blake Simmons, Patrick Vollmer, et al.
Investigative Ophthalmology & Visual Science
|
January 11, 2019
Randomized, Controlled, Double-Masked, Multicenter, Pilot Study Evaluating Safety and Efficacy of Intranasal Neurostimulation for Dry Eye Disease
Geoffrey S Cohn, Dean Corbett, Abi Tenen, et al.
Kyobu Geka. the Japanese Journal of Thoracic Surgery
|
January 1, 1978
[Intraoperative and postoperative immediate autotransfusion in open heart surgery under profound hypothermia without pump-oxygenator--development of an immediate autotransfusion system and its clinical applications (author's transl)]
K Matsumoto, Y Koga, N Baba, et al.
Cornea
|
February 9, 2024
Long-Term Outcomes of 6-Week Treatment of Lotilaner Ophthalmic Solution, 0.25%, for Demodex Blepharitis: A Noninterventional Extension Study
Ehsan Sadri, James D Paauw, Joseph B Ciolino, et al.
ESMO Open
|
November 28, 2021
Anti-PD-1 antibody monotherapy versus anti-PD-1 plus anti-CTLA-4 combination therapy as first-line immunotherapy in unresectable or metastatic mucosal melanoma: a retrospective, multicenter study of 329 Japanese cases (JMAC study)
Y Nakamura, K Namikawa, S Yoshikawa, et al.
Page
of 29